Evidence map›Paper›PMID 37415954›Full record

ArticleIJID regions2023

Outcomes among Thai children with risk conditions hospitalized for pneumococcal disease (invasive or non-bacteraemic pneumonia): A multi-centre, observational study.

Wanatpreeya Phongsamart, Kristen E Allen, Warunee Punpanich Vandepitte, Chonnamet Techasaensiri, Pope Kosalaraksa, Kamolwish Laoprasopwattana, Puttichart Khantee, Songkiat Udompornwattana, Detchvijitr Suwanpakdee, Tavitiya Sudjaritruk and 9 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in IJID regions, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 11 institutions in 3 countries.

Wanatpreeya PhongsamartDepartment of Paediatrics, Division of Infectious Diseases, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Kristen E AllenPfizer Biopharma Group, Collegeville, PA, USA.
Warunee Punpanich VandepitteQueen Sirikit National Institute of Child Health, Bangkok, Thailand.
Chonnamet TechasaensiriDivision of Infectious Diseases, Department of Paediatrics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Pope KosalaraksaDivision of Infectious Disease, Department of Paediatrics, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Kamolwish LaoprasopwattanaDepartment of Paediatrics, Faculty of Medicine, Prince of Songkla University, Songkla, Thailand.
Puttichart KhanteeDepartment of Paediatrics, Faculty of Medicine, Prince of Songkla University, Songkla, Thailand.
Songkiat UdompornwattanaBuddhachinaraj Hospital, Phitsanulok, Thailand.
Detchvijitr SuwanpakdeePaediatric Infectious Disease Unit, Phramongkutklao Hospital, Bangkok, Thailand.
Tavitiya SudjaritrukDepartment of Paediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Thanyawee PuthanakitDivision of Paediatric Infectious Diseases, Department of Paediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Suvaporn AnugulruengkittDivision of Paediatric Infectious Diseases, Department of Paediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Jo SouthernPfizer Biopharma Group, Collegeville, PA, USA.
Mark A FletcherPfizer Biopharma Emerging Markets Medical Affairs, Vaccines, Paris, France.
Eileen M DunnePfizer Biopharma Group, Collegeville, PA, USA.
Ruangwit ThamareePfizer Biopharma Group, Emerging Markets Asia, Bangkok, Thailand.
Graciela MoralesPfizer Biopharma Group, Collegeville, PA, USA.
Kulkanya ChokephaibulkitDepartment of Paediatrics, Division of Infectious Diseases, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Tawee ChotpitayasunondhQueen Sirikit National Institute of Child Health, Bangkok, Thailand.
Pfizer (United States) · USChulalongkorn University · THPrince of Songkla University · THQueen Sirikit National Institute of Child Health · THSiriraj Hospital · THBuddhachinaraj Hospital · THChiang Mai University · THKhon Kaen University · THMahidol University · THPfizer (France) · FRPhramongkutklao Hospital · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To describe the risk condition status and clinical outcomes among Thai children hospitalized with pneumococcal disease. Methods: In this retrospective analysis, children with invasive pneumococcal disease (IPD) or x-ray-confirmed non-bacteraemic pneumococcal pneumonia (NBPP) were identified from nine hospitals in Thailand between 2010 and 2019. Data on risk factors and outcomes were extracted from medical records. Results: In total, 413 cases were identified: 319 IPD and 94 NBPP. Overall, 133 (32.2%) patients were admitted to intensive care units and 11/406 (2.7%) died. Twenty-seven percent of IPD cases had at-risk conditions and 15% had high-risk conditions. Most IPD cases (32.9%) occurred in children aged 2-4 years, and most NBPP cases (28.7%) occurred in infants aged 0-11 months. Of 51 Conclusions: Most children with IPD and NBPP did not have high-risk or at-risk conditions, while 42% had at-risk or high-risk conditions for pneumococcal disease. Very few children in the cohort had received any type of pneumococcal vaccine. Increasing the availability of pneumococcal conjugate vaccines should be considered to reduce the burden of pneumococcal disease among children in Thailand.

Indexed as

Invasive pneumococcal disease (IPD)Non-bacteraemic pneumococcal pneumoniaPCV13Pneumococcal conjugate vaccinePneumococcal pneumonia

Identifiers

PMID37415954
PMCPMC10319896
OpenAlexW4379471985

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.